Segments - Continuous Positive Airway Pressure Masks Market by Mask Type (Nasal Masks, Pediatric Masks, Nasal Pillows, Full Face Masks, and Others), Patient Type (Pediatric and Adults), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospital Pharmacy, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global continuous positive airway pressure (CPAP) masks market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of XX% during 2023–2031. The market growth is attributed to the rise of sleep apnea/hypopnea syndrome and breathing disorders.
Rising obesity disorders, hypertension, and diabetes are resulting in increased cases of sleep apnea/hypopnea syndrome (SAHS) among the global population. Sleep apnea symptoms include loud snoring, breathing difficulties during sleep, insomnia, and morning headaches. CPAP therapy is a major treatment for treating these disorders.
The CPAP machine utilizes a hose-attached mask or nosepiece to provide consistent air pressure, enabling patients to breathe effortlessly and sleep well. Growing cases of sleep apnea is leading to the emergence of various innovative CPAP masks and other devices in the market, to meet the rising demand. This is projected to create growth potential for the players in the market.
According to the study published by the National Council on Aging (NCOA) on October 11, 2023, around 936 million adults worldwide are likely to have mild to severe obstructive sleep apnea (OSA). In the US, this count is estimated to be 39 million adults approximately.
The research report finds that the COVID-19 pandemic fueled the continuous positive airway pressure masks market. Individuals with sleep apnea disorders were at high risk of being affected by this virus. The demand for CPAP masks surged during this period, as orders from severely affected countries, such as China, Germany, the US, and Italy, skyrocketed.
These masks registered high demand for the purpose of effectively managing patients who had severe respiratory complications. Organizations such as the FDA issued several emergency guidelines, which allowed the use of CPAP masks and devices as an alternative.
An updated study published by the Sleep Foundation in November 2022 revealed that individuals with OSA have high risk of being infected with COVID-19. The hospitalization rate for such individuals is likely to be more than that of normal individuals being infected with the virus.
The growth of AI in various healthcare fields is likely to have a considerable impact on the market in the coming years. The deep learning and quick analysis features of this technology are likely to enable quick improvements in sleep and breathing-related conditions with CPAP devices.
The analytics capabilities of AI are anticipated to help predict the risk of non-adherence to CPAP therapy early during the treatment. This is likely to support medical practitioners in integrating tailored interventions in therapy to modify the predicted outcomes.
According to a study published in September 2023, researchers performed an analysis on 21,397 subjects in terms of CPAP usage. Based on this analysis, an AI model was developed to predict the outcomes of CPAP therapy at three points, namely, 3 months, 6 months, and a year into the therapy. The model aided in predicting likely outcomes of the therapy within one to two weeks into the treatment.
Increasing prevalence of obstructive sleep apnea and rising cases of chronic obstructive pulmonary disease (COPD) are driving the market. CPAP devices such as masks of various types are commonly used for treating these disorders. The devices pass pressurized air through the patient’s airway with tubing and a CPAP mask.
Several types of CPAP masks are available in the market, which are developed based on key requirements of patients with breathing disorders, such as breathing habits, comfort level, and type of sleep apnea. Some examples of these masks are full masks, nasal masks, and nasal pillow masks, among others.
As per the information published on March 16, 2023, by the World Health Organization (WHO), COPD is the seventh-ranking cause of poor health across the world. It is the third major cause of death globally. It caused about 3.23 million fatalities in 2019. Several physicians recommend CPAP or BiPAP masks to COPD patients for ease of breathing.
High cost of the product is likely to affect the market over the projected period. The cost of quality CPAP masks varies and is usually expensive. This is a costly affair for patients belonging to low to middle-income countries. Additionally, the discomfort caused by CPAP masks to patients affects the demand for these masks.
Availability of locally manufactured CPAP masks at lower cost is likely to hinder the market. The quality of such masks does not always meet standards set by the government and private organizations. However, patients are likely to prefer the masks over the ones developed by the big corporations, due to their cheap prices and ease of source.
Growing spending on healthcare treatments and advances in healthcare technology are expected to create opportunities in the market. The rise of disposable income, especially in developing nations, is boosting the demand for improved healthcare and medical devices at a steady pace.
Various governments are making proactive efforts towards expanding healthcare reach and quality, which is likely to support the market growth. Additionally, the growing exploration of technologies, such as AI, Machine Learning, Internet of Things (IoT), and others, are likely to benefit the players in the market by expanding opportunities in the market.
The global market research report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Continuous Positive Airway Pressure Masks Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Mask Type (Nasal Masks, Pediatric Masks, Nasal Pillows, Full Face Masks, and Others), Patient Type (Pediatric and Adults); and Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospital Pharmacy, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
AG industries; Air Liquide Medical Systems; APEX MEDICAL DEVICES; BMC; Drägerwerk AG & Co. KGaA; Drive DeVilbiss International; Fisher & Paykel Healthcare Limited.; Hamilton Medical; Hans Rudolph, Inc.; Intersurgical Ltd; KOIKE MEDICAL CO., LTD; Koninklijke Philips N.V.; Medline industries, Inc.; ResMed; Sarnova, Inc.; Sleepnet Corporation; Sunset Healthcare Solutions; Teleflex Incorporated; and VYAIRE MEDICAL, INC. |
Based on mask type, the continuous positive airway pressure masks market is divided into nasal masks, pediatric masks, nasal pillows, full face masks, and others. The nasal pillows segment is expected to expand at a substantial growth rate during the projection period, owing to their benefits such as comfort of wearing and low-profile design. Nasal pillow CPAP masks fit easily in between an individual’s upper lip and nose. It is unobtrusive and fairly small, hence, individuals find it easy to use.
According to the study published on May 25, 2023, by the Sleep Foundation, Nasal pillow CPAP masks are highly suitable for people who have the habit of shifting sleep positions often. It is also suitable for those individuals who find wearing full face masks uncomfortable. People with facial hair find that these masks seal against the face efficiently.
The nasal masks segment is anticipated to register rapid growth in demand during the projection period. These masks are commonly available in pharmacies, which drives their demand. They cover the entire nasal region or bottom half of the nose, supplying pressurized air into the nostrils. It is comfortable to use as compared to full-face masks, allowing individuals to view TV or read.
On the basis of patient type, the global market is bifurcated into pediatric and adults. The adults segment is projected to lead the market in terms of usage during the forecast period, owing to the rising risk of sleep apnea with the increasing age. Individuals face several health issues with the aging process. Breathing complications, irregular sleep cycles, sleep apnea, diabetic conditions, and other chronic illnesses are commonly reported by adults.
On the basis of distribution channel, the continuous positive airway pressure masks market is segmented into retail pharmacy, online pharmacy, hospital pharmacy, and others. The retail pharmacy segment is expected to register robust growth during the forecast period, owing to the growing availability of innovative sleep apnea devices in these pharmacies.
Expansion of retail pharmacy with the rise of urbanization and healthcare infrastructure development in emerging countries is likely to expand the opportunities in the market. Increasing income levels and rising expenditure on healthcare products are expected to further drive this segment during the projection period.
In terms of region, the global continuous positive airway pressure masks market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America is expected to dominate the market during the forecast period, owing to rising cases of sleep apnea among the population in the region. Development of technology and medical devices for the treatment of sleep disorders in the region further creates opportunities in the market. Presence of key players coupled with the growing focus on research and development of smart sleep technology are expected to boost the market in this region.
According to the recent data published by HOUSTON SLEEP SOLUTIONS, 2% to 4% have undiagnosed sleep apnea. This means about 1 in 50 US citizens has undiagnosed sleep apnea.
The market in Asia Pacific is projected to expand at a rapid growth rate, due to increasing expenditure on healthcare and high demand for quality treatment and medical devices in the region. Rising investment from various national governments to promote sleep-related awareness and the wide availability of various healthcare devices to the general population are boosting the regional market.
Increasing presence of quality healthcare devices and supplies manufacturers in the region is expected to boost the market. Rise of medical tourism and growing research & development of medical products for sleep and breathing solutions are likely to widen opportunities in this regional market.
The global continuous positive airway pressure masks market has been segmented on the basis of
Key players competing in the continuous positive airway pressure masks market are AG industries; Air Liquide Medical Systems; APEX MEDICAL DEVICES; BMC; Drägerwerk AG & Co. KGaA; Drive DeVilbiss International; Fisher & Paykel Healthcare Limited.; Hamilton Medical; Hans Rudolph, Inc.; Intersurgical Ltd; KOIKE MEDICAL CO., LTD; Koninklijke Philips N.V.; Medline industries, Inc.; ResMed; Sarnova, Inc.; Sleepnet Corporation; Sunset Healthcare Solutions; Teleflex Incorporated; and VYAIRE MEDICAL, INC.
These companies adopted development strategies, including mergers, acquisitions, partnerships, collaborations, product launches, and production expansion to expand their consumer base worldwide. The competitive landscape covers key insights into growth strategies adopted by major market players.
In September 2023, RemSleep Holdings Inc., a manufacturer of medical devices dedicated to OSA, announced the completion of the testing protocol for 510K clearance of DeltaWave CPAP Mask. It successfully completed all of the tests required for the clearance, including MLA and Cytotoxicity tests, which had to go through retesting in the past.
In July 2023, ResMed, one of the key companies in the market, announced the acquisition of Somnoware, a privately-owned firm and key sleep and respiratory care diagnostics software solution provider in the US.